Clinical and histological characteristics of papillary thyroid microcarcinoma: Results of a retrospective study in 243 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2171-2178

  Roti, Elio ^a   Rossi, Roberta ^b   Trasforini, Giorgio ^b   Bertelli, Fiorenza ^b   Ambrosio, Maria Rosaria ^b   Busutti, Luciano ^c   Pearce, Elizabeth N ^d,e   Braverman, Lewis E ^d   Degli Uberti, Ettore C ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Malpighi Hospital   (Italy)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; UNIVERSITY HOSPITAL;

BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33744949190     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2372     Document Type: Article

References (40)

1. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559
2. Mazzaferri EL, Massoll N 2002 Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9:227-247
3. Castro MR, Gharib H 2005 Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926-931
4. Harach MR, Franssila KO, WaseniusVM1985 Occult papillary of the thyroid: a normal finding in Finland. A systematic autopsy study. Cancer 56:531-538
5. Hedinger C, Williams ED, Sobin LH 1988 Histological typing of thyroid tumours. International histological classification of tumours. World Health Organization. 11th vol, 2nd ed. Berlin: Springer-Verlag
6. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayeshi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A 2003 An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381-387
7. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M 1998 Microcarcinoma of the thyroid gland: the Gustave Roussy Institute experience. Cancer 83:553-559
8. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147
9. Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH 2003 Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000. Clin Oncol 15:329-336
10. Rodriguez JM, Parilla MP, Sola J, Soria T, Tebar FJ, Aranda F 1997 Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 163:255-259
11. Sugino K, Ito K, Ozaki O, Mimura T, Iwassaki H, Ito K 1998 Papillary microcarcinoma of the thyroid. J Endocrinol Invest 21:445-448
12. Braga M, Graf H, Ogata A, Batista J, Hakim Neto CA 2002 Aggressive behaviour of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass. J Endocrinol Invest 25:250-253
13. Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, Watanabe S, Kawamoto H 1999 Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86:842-849
14. Noguchi S, Yamashita H, Murakami N, Nakayama I, Masakatsu T, Kawamoto H 1996 Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 131:187-191
15. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A 2004 Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720
16. Shah JP, Kian K, Forastiere A, Garden A, Hoffman HT, Jack Lee J, Lydiatt W, Medina JE, Mukherji S, Oliva ME, O'Sullivan B, Paulino A, Singh B, Weber R, Weymuller E 2002 American Joint Committee on Cancer. Cancer staging manual. 6th ed. New York: Springer-Verlag; 77-87
17. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Warofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441
18. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A, Wiersinga WM 2004 Follow-up of low-risk patients with differentiated thyroid carcinoma: a European prospective. Eur J Endocrinol 150:105-112
19. Pelizzo MR, Boschin IM, Toniato A, Pagetta C, Piotto A, Bernante P, Casara D, Pennelli G, Rubello D 2004 Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun 25:547-552
20. Mazzaferri EL, Young RL 1981 Papillary thyroid carcinoma: a 10 year follow-up. Report of the impact of therapy in 576 patients. Am J Med 70:511-518
21. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89:202-216
22. Garrel R, Cartier C, Marvaso V, Corpelet D, Makeieff M, Crampette L, Guerrier B 2002 Our experience with papillary microcarcinoma of the thyroid. Rev Laryngol Otol Rhinol 123:239-242
23. Ortiz S, Rodriguez JM, Torregrosa N, Balsalobre M, Rios A, Parrilla P 2003 Relation between clinical presentation and prognosis of patients with papillary thyroid microcarcinoma. Med Clin (Barc) 31:773-774
24. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B 1990 High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 76:255-257
25. Giles Y, Boztepe H, Terzioglu T, Tezelman S 2004 The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg 139:179-182
26. Pearce EN, Braverman L 2004 Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 89:3710-3712 (Editorial)
27. Sawka AM, Kullathorn T, Brouwers M, Thabane L, Browman G, Gerstein HC 2004 A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668-3676
28. Appetecchia M, Scarcello G, Pucci E, Procaccini A 2002 Outcome after treatment for papillary thyroid microcarcinoma. J Exp Clin Cancer Res 21:159-164
29. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y 2003 Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407
30. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL 1998 Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83:4116-4122
31. Shattuck TM, Westra WH, Ladenson PW, Arnold A 2005 Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 352:2406-2412
32. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR 1999 Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637-639
33. Stocker DJ, Burch HB 2003 Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol 28:205-212
34. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R 1988 Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab 83:2805-2809
35. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudo HK, Kuma K, Tamai H 1995 The correlation between papillary thyroid carcinoma and lymphocytic infiltration of the thyroid gland. J Clin Endocrinol Metab 80:3421-3424
36. Kovacs GL, Gonda G, Vadasz G, Ludmany E, Uhrin K, Gorombey Z, Kovacs L, Hubina E, Bodo M, Goth MI, Szabolcs I 2005 Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15:152-157
37. Viglietto G, Chiappetta G, Martinez-Tello FJ, fukunaga FH, Tallini G, Rigoupoulou D, Visconti R, Mastro A, Santoro M, Fusco A 1995 RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11:1207-1210
38. Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A 1998 RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly or undifferentiated tumor phenotypes. Clin Cancer Res 4:287-294
39. Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S, Asa SL 1996 RET/PTC1, 2 and 3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 81:3360-3365
40. Oler G, Ebina KN, Mchaluart P, Rimura ET, Cerutti J 2005 Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched lymphnode metastasis reveals a new mutation in metastasis. Clin Endocrinol (Oxf) 62:509-511